🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the MTD of WGI-0301 in combinatio...
Status
Recruiting
Location
China Pharmaceutical University, Shanghai Gobroad Cancer Hospital
Start Date
2024-07-31
Trial ID
NCT06309485
Background: Sorafenib is a drug that has been approved to treat kidney and...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2011-02-11
Trial ID
NCT01306058
RATIONALE: Drugs used in chemotherapy, such as cisplatin and carboplatin, w...
Status
Completed
Location
University of Miami Sylvester Comprehensive Cancer Center - Miami
Start Date
2008-12
Trial ID
NCT00875615
Treatments Being Tested
* Unlike the Asian and western regions, The vast majority of the Egyptian/A...
Status
Terminated
Location
Ain shams university
Start Date
2012-01
Trial ID
NCT01539018
Treatments Being Tested
This phase I trial is studying the side effects and best dose of vorinostat...
Status
Completed
Location
Hunter Holmes McGuire VA Medical Center
Start Date
2010-08-10
Trial ID
NCT01075113
Treatments Being Tested
The purpose of this study is to find out what effects, good and/or bad, the...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2009-02
Trial ID
NCT00837148
Treatments Being Tested
This is multicentre, open-label, randomized, phase II trial in patients wit...
Status
Unknown
Location
A.O. Universitaria Ospedali Riuniti Umberto I
Start Date
2007-08
Trial ID
NCT00758381
Treatments Being Tested
This study is to assess sorafenib as second treatment for patients that hav...
Status
Terminated
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00678288
Treatments Being Tested